"Humanitas Gavazzeni è un ospedale polispecialistico privato accreditato con il Servizio Sanitario Nazionale per le attività ambulatoriali e di ricovero. Situato nella zona centrale di Bergamo, all’interno di un parco secolare, rappresenta un modello innovativo di ospedale, caratterizzato da una filosofia che privilegia nell’organizzazione ospedaliera il rapporto umano con il paziente e che integra l’efficacia clinica con l’efficienza gestionale. La struttura è accreditata da Joint Commission International, ente internazionale certificatore in campo sanitario che individua e condivide con molti paesi del mondo le pratiche migliori per la qualità e la sicurezza dei pazienti."

During the past decade, Cliniche Humanitas Gavazzeni conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 7 clinical trials were completed, i.e. on average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cliniche Humanitas Gavazzeni" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 2 trials sponsored, "Medtronic Bakken Research Center" with 2 trials sponsored and "Biotronik SE & Co. KG" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cliniche Humanitas Gavazzeni" #1 collaborator was "A.O.U. Città della Salute e della Scienza - Molinette Hospital" with 1 trials as a collaborator, "Agenzia Italiana del Farmaco" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cliniche Humanitas Gavazzeni" with 1 trials as a collaborator and "Clirest s.r.l." with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Cliniche Humanitas Gavazzeni" are "Heart Failure" (3 trials), "Malignant Pleural Mesothelioma" (2 trials), "Mesothelioma" (2 trials), "Advanced Colorectal Cancer" (1 trials) and "Arthroplasty, Replacement, Knee" (1 trials). Many other conditions were trialed in "Cliniche Humanitas Gavazzeni" in a lesser frequency.

Most popular intervention types in "Cliniche Humanitas Gavazzeni" are "Drug" (16 trials), "Device" (7 trials), "Other" (4 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Cisplatin" (2 trials), "Pemetrexed" (2 trials), "ACE inhibitor Ramipril" (1 trials) and "ADI-PEG 20 plus Pem Cis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cliniche Humanitas Gavazzeni" are 24 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Cliniche Humanitas Gavazzeni". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Cliniche Humanitas Gavazzeni, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cliniche Humanitas Gavazzeni, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".